is aod9604 fdaapproved AOD-9064 Fat-Metabolizing Peptide Fragment WHAT IT • Synthetic fragment of human growth hormone • Targets the fat-burning domain only • Does not significantly increase IGF-1 or affect glucose • Designed for AOD-9604 Dosage Guide: Complete Protocol
Description
AOD-9604 does not affect IGF-1 because it lacks the receptor-binding domains necessary to activate growth hormone receptors
The increased NAD+ availability supports more efficient ATP (cellular energy) production, potentially translating to better endurance, improved workout performance, and faster recovery between training sessions
Its Dispovan syringes are among the leading single-use syringes used across hospitals and clinics in the country
Athletes subject to drug testing should be aware that use could result in positive tests and associated consequences
